Manages suspected mild central hypothyroidism in patients with pituitary disease and low-normal free thyroxine (fT4). Initiates levothyroxine (L-T4) when suggestive symptoms are present or when serial fT4 shows a decrease of 20% or more.
Scanned 9/9/2026
Install to Claude Code
npx -y skills add dromlakhani/MD2SKILL --skill ata-mild-ch-management --agent claude-codeInstalls into .claude/skills of the current project.
Are you the author of Ata Mild Ch Management?
Add the live security badge to your README — it updates automatically with every re-scan.
[](https://www.skillsdirectory.com/skills/dromlakhani-ata-mild-ch-management)More formats (shields.io, HTML) on the badges page.
---
name: ata-mild-ch-management
description: Manages suspected mild central hypothyroidism in patients with pituitary disease and low-normal free thyroxine (fT4). Initiates levothyroxine (L-T4) when suggestive symptoms are present or when serial fT4 shows a decrease of 20% or more.
---
# Manage suspected mild central hypothyroidism with low-normal fT4
## STEP 1 — Gather Information
Confirm pituitary disease history or imaging; measure serum fT4; assess for suggestive hypothyroid symptoms (fatigue, cold intolerance, constipation, dry skin, weight gain, menorrhagia).
## STEP 2 — Rule In / Rule Out
If pituitary disease is absent or fT4 is not low-normal (i.e., below reference range or markedly elevated), rule out mild CH and evaluate for primary thyroid disease or other causes; otherwise proceed.
## STEP 3 — Classify or Stratify
If suggestive symptoms are present, classify as "treat now"; if absent, classify as "monitor serial fT4".
## STEP 4 — Decide
If classified as treat now, start levothyroxine (L-T4) at a low dose (e.g., 25–50 µg daily) and titrate based on clinical response and fT4; if classified as monitor, repeat fT4 in 6–12 weeks and start L-T4 if the level decreases by ≥20% from baseline.
## Clinical Guardrails / Mimics / Pitfalls
Do not rely on TSH alone to diagnose or monitor CH; evaluate for adrenal insufficiency before initiating L-T4 to avoid precipitating adrenal crisis; avoid over-replacement targeting fT4 above the upper reference limit; be aware that GH therapy may mask CH by maintaining fT4 in the reference range.
## Concrete Clinical Example
A 48-year-old man with a nonfunctioning pituitary macroadenoma has fT4 0.85 ng/dl (reference 0.70–1.48) and mild fatigue. Repeat fT4 at 3 months is 0.66 ng/dl, a 22% decrease. Start L-T4 25 µg daily, recheck fT4 in 6 weeks.
**Source:** Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, doi:10.1210/jc.2016-2118
> **TODO:** consider adding scripts/calc.py for the ata-mild-ch-management calculator
Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.
No comments yet. Be the first to comment!